FPMAJ Chief Advocates Drug Price Revision Rule Based on Appropriate Margins for Each Player

FPMAJ Chairman Sunao Manabe Japan should build an NHI price revision rule that would swiftly reflect the declines in manufacturers’ shipment prices to reimbursement prices while ensuring appropriate margins for each healthcare stakeholder, pharma industry leader Sunao Manabe told Jiho...read more